Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Pulmonary and pleural involvements at initial diagnosis in children with malignant neoplasmE Ishii, S Yamada, S Kano, et al.
Scandinavian Journal of Immunology|October 1, 1995
Secretion of MPB64 antigen by a recombinant clone of Mycobacterium smegmatis: characterization and application for the diagnosis of tuberculosisH Tasaka, E Shigeto, K Matsuo, et al.
Pediatric Hematology and Oncology|May 1, 1995
An effective salvage regimen with aclarubicin for daunorubicin-resistant acute non-lymphocytic leukemia in childrenK Nibu, F Yanai, J Okamura, et al.
Kekkaku : [Tuberculosis]|September 1, 1991
[Study on recombinant BCG]K Matsuo, R Yamaguchi, A Yamazaki, et al.
Journal of Pediatric Surgery|May 1, 1994
How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of JapanS Suita, Y Zaizen, H Yano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 1, 1994
[Bone marrow transplantation for a patient with ALL from her 75-year-old mother using cryopreserved bone marrow cells]N Uike, Y Suehiro, H Takahira, et al.
Acta Haematologica|January 1, 1991
Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factorE Ishii, S Ohga, T Aoki, et al.
Journal of Pediatric Surgery|May 1, 1995
Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu areaS Suita, Y Zaizen, Y Sera, et al.
Kekkaku : [Tuberculosis]|May 1, 1994
[Responsiveness of lymphocytes from patients with M. avium-intracellulare complex (MAC) infection to PPDs as measured by IFN-gamma production]K Tomoda, T Yoneda, K Tsukaguchi, et al.
Journal of Pediatric Surgery|February 1, 1989
Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimenK Ikeda, A Nakagawara, H Yano, et al.
Pageof 7